PTHS · Pelthos Therapeutics Inc.
$27.50
-1.45 (-5.01%)
At close · Aug 14
Market Cap
$105.28M
Shares
3.83M
Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.
Program Authorized
$1,250,000
as of 2024-10-22
· total across 2 concurrent programs
Concurrent Repurchase Programs
| Authorized | As of | Remaining | Remaining as of | Source |
|---|---|---|---|---|
| $500,000 | 2024-10-22 | — | — | 10-Q, filed 2025-08-13 |
| $750,000 | 2024-10-22 | — | — | 10-Q, filed 2025-08-13 |
Repurchase History
| Fiscal Year Ended | Cash Spent | Source |
|---|---|---|
| 2025-12-31 | $0 | 10-K, filed 2026-03-19 |
| 2024-12-31 | $75,000 | 10-K, filed 2026-03-19 |
Key facts
CIK
1919246
CUSIP
171126204
13F (30d)
24 filings
24 filers
Visit website
Investor relations